Amarantus CEO Gerald Commissiong Elected to Biotec
Post# of 30028
Posted On: 02/07/2015 2:46:16 PM
Amarantus CEO Gerald Commissiong Elected to Biotechnology Industry Organization Committees
SAN FRANCISCO and GENEVA, Oct. 20, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the development of diagnostics and therapeutics for Alzheimer's disease, Parkinson's disease and ophthalmological disorders, announced that President & CEO, Gerald Commissiong, was elected to three Biotechnology Industry Organization("BIO"
committees: the Healthcare Reform & Reimbursement Committee , the Personalized Medicine and Diagnostics Working Group , and the 17th Annual BIO CEO & Investor Conference Advisory Committee.
"BIO is a critical organization that represents the biopharmaceutical industry to work with policy-makers who set guidelines for biotechnology product development and commercial oversight in the United States," said Gerald E. Commissiong, President & CEO of Amarantus. "I'm very happy to become formally involved in this important effort. BIO is the world's largest trade organization representing biotech organizations across the United States and in more than 30 other nations. Its initiatives include improving products, from development to commercialization, which are invaluable to patients in the safest and most efficacious manner possible."
https://www.bio.org/events/conferences/bio-ce...-committee
Scroll down
I forgot all 3 Committees were all for "BIO"
Cheers
SAN FRANCISCO and GENEVA, Oct. 20, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the development of diagnostics and therapeutics for Alzheimer's disease, Parkinson's disease and ophthalmological disorders, announced that President & CEO, Gerald Commissiong, was elected to three Biotechnology Industry Organization("BIO"
committees: the Healthcare Reform & Reimbursement Committee , the Personalized Medicine and Diagnostics Working Group , and the 17th Annual BIO CEO & Investor Conference Advisory Committee. "BIO is a critical organization that represents the biopharmaceutical industry to work with policy-makers who set guidelines for biotechnology product development and commercial oversight in the United States," said Gerald E. Commissiong, President & CEO of Amarantus. "I'm very happy to become formally involved in this important effort. BIO is the world's largest trade organization representing biotech organizations across the United States and in more than 30 other nations. Its initiatives include improving products, from development to commercialization, which are invaluable to patients in the safest and most efficacious manner possible."
https://www.bio.org/events/conferences/bio-ce...-committee
Scroll down
I forgot all 3 Committees were all for "BIO"
Cheers
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼